Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for Epilepsy-related Cognitive Deficits
NCT04419272Phase 4Recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Aug 2023
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate in epilepsy, sponsored by VA Office of Research & Development. Started Aug 2023; status: recruiting.
02
Drugs
methylphenidate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT04419272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04419272.